Dr. Kevin Bugin, Deputy Director of Operations at CDER, U.S. FDA, shares insights on the impact of a single line of code that nearly disrupted the internet. His expertise in drug evaluation and clinical trial innovation adds depth to this fascinating tale, offering a unique perspective on technology's intersection with healthcare.